Cancer Drug Update: Eli Lilly says Jaypirca (pirtobrutinib) added to a time-limited venetoclax + rituximab regimen cut the risk of progression or death by 45% in relapsed/refractory CLL/SLL, with results from the Phase 3 BRUIN CLL-322 trial. Healthcare Access & Policy: India’s PM Modi touted Ayushman Bharat as the world’s largest healthcare programme, pointing to expanded coverage and lower out-of-pocket burdens. Workforce & Care Continuity: England resident doctors called off planned strikes after a last-minute government pay and progression offer, though some disruption is still expected. Mental Health Wait Times: Kaiser Permanente mental health therapists in Hawaii say patients still face long waits for appointments despite ongoing negotiations. Cardiovascular Lifestyle Research: A UK Biobank study links about three cups of tea daily with a 17% lower risk of major heart events in people with established coronary heart disease. Fraud & Oversight: LA County hospice fraud is escalating, with federal and state actions targeting sham billing and repeat offenders. Global Public Health: HHS announced a CDC-led tick-control pilot in New Hampshire aimed at reducing Lyme disease cases by targeting ticks on deer and mice. Local Care & Innovation: Fitzwilliam Hospital in Peterborough launched robotic Aquablation for benign enlarged prostate, aiming to reduce side effects. Patient Safety & Accountability: Author Chimamanda Adichie again accuses Euracare Hospital in Lagos of delaying an inquest into her son’s death. Community Health: A Pakistan-Nepal medical camp in Kathmandu examined 100+ patients and provided free medicines, with referrals for specialized care.